Spinal Muscular Atrophy (SMA) Latest Advances

Find the Latest Research About Spinal Muscular Atrophy (SMA)

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10626 publications

Beyond Survival: Parenting and Psychosocial Support in the New Era of Spinal Muscular Atrophy.

Beyond Survival: Parenting and Psychosocial Support in the New Era of Spinal Muscular Atrophy.

Journal: Journal of child neurology
Published: June 24, 2026

Exploring Treatment Expectations and Clinical Meaningfulness in Spinal Muscular Atrophy Using the Goal Attainment Scale.

Exploring Treatment Expectations and Clinical Meaningfulness in Spinal Muscular Atrophy Using the Goal Attainment Scale.

Journal: Archives of rehabilitation research and clinical translation
Published: June 22, 2026

A Gene, A Breakthrough, A Challenge: Lessons From the History of Spinal Muscular Atrophy.

A Gene, A Breakthrough, A Challenge: Lessons From the History of Spinal Muscular Atrophy.

Journal: Journal of child neurology
Published: June 13, 2026

18F FDG-PET correlates of motor neuron disease motor variants.

18F FDG-PET correlates of motor neuron disease motor variants.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: June 09, 2026

Determinants of hepatic enzyme elevations following onasemnogene abeparvovec: Results from a unified immunomodulation protocol.

Determinants of hepatic enzyme elevations following onasemnogene abeparvovec: Results from a unified immunomodulation protocol.

Journal: Journal of neuromuscular diseases
Published: June 04, 2026

Medication Usage in Motor Neuron Disease and Spinal Muscular Atrophy: Insights from the Muscular Dystrophy Association Neuromuscular Observational Research Data Hub.

Medication Usage in Motor Neuron Disease and Spinal Muscular Atrophy: Insights from the Muscular Dystrophy Association Neuromuscular Observational Research Data Hub.

Journal: Journal of clinical neuromuscular disease
Published: June 02, 2026

External controls for rare disease drug development: Lessons for emerging and advanced therapeutic modalities.

External controls for rare disease drug development: Lessons for emerging and advanced therapeutic modalities.

Journal: Molecular therapy. Advances
Published: May 29, 2026

Correction: Clinical outcome and efficacy of nusinersen in Korean adult patients with 5q spinal muscular atrophy: Nationwide multicenter retrospective study.

Correction: Clinical outcome and efficacy of nusinersen in Korean adult patients with 5q spinal muscular atrophy: Nationwide multicenter retrospective study.

Journal: Acta neurologica Belgica
Published: May 28, 2026

Ten years of disease-modifying therapy in spinal muscular atrophy: lessons learned and future directions.

Ten years of disease-modifying therapy in spinal muscular atrophy: lessons learned and future directions.

Journal: Nature reviews. Neurology
Published: May 26, 2026

Autonomic Nervous System Phenotyping Across Chronic Demyelinating Peripheral Neuropathies: A Comparative Study.

Autonomic Nervous System Phenotyping Across Chronic Demyelinating Peripheral Neuropathies: A Comparative Study.

Journal: Journal of the peripheral nervous system : JPNS
Published: May 25, 2026

Target-Based Discovery of Drug Combinations for Spinal Muscular Atrophy.

Target-Based Discovery of Drug Combinations for Spinal Muscular Atrophy.

Journal: Advances in experimental medicine and biology
Published: May 24, 2026

Farber Lipogranulomatosis With Spinal Muscular Atrophy With Progressive Myoclonic Epilepsy: Expanding the Phenotypic Spectrum.

Farber Lipogranulomatosis With Spinal Muscular Atrophy With Progressive Myoclonic Epilepsy: Expanding the Phenotypic Spectrum.

Journal: Journal of child neurology
Published: May 23, 2026
Showing 1-12 of 10,626

Last Updated: 06/30/2026